The top 10 biopharma stock gainers and losers for the week.

A quick look back at top stories.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alk-Abello, Bavarian, BMS, Ferring, Scpharmaceuticals.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Kancera, Novakand, Orgenesis, Recardio, Virpax.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Avacta, Atyr, Biocon, Eli Lilly, Sun, Torqur.

Biopharmas raising money in public or private financings, including: Acurx, Medicus.

New hires and promotions in the biopharma industry, including: Rigel, Schrödinger, Sernova, Unity.

These graphs compare the performance of the biotech stocks for all of 2024 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2024.